Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Merck and CDRD Announce Joint Investment in the Canadian Life Sciences Ecosystem
Saturday, November 04, 2017The Canadian scientific community gathered in Ottawa this week to engage in a national dialogue on science technology and innovation policy at the annual Canadian Science Policy Conference Just prior to the Keynote Address at this event by the Honour...
WuXi Biologics and Pall Corporation Establish Joint Continuous Bioprocess Laboratory
Friday, November 03, 2017WuXi Biologics a global leading openaccess biologics technology platform company offering endtoend solutions for biologics discovery development and manufacturing and its partner Pall Corporation the global leader of advanced filtration separation an...
Boehringer Ingelheim and Dicerna Announce Collaboration to Develop Novel Treatments for Chronic Liver Diseases
Friday, November 03, 2017Boehringer Ingelheim and Dicerna Pharmaceuticals a leading developer of investigational RNA interference RNAi therapeutics today announced a research collaboration and license agreement to discover and develop novel GalXC RNAi therapeutics for the tr...
Teva Announces Completion of PARAGARD® Divestiture to CooperSurgical
Thursday, November 02, 2017Teva Pharmaceutical Industries Ltd announced it has completed the divestiture of PARAGARD intrauterine copper contraceptive to CooperSurgical in a billion cash transaction This transaction includes Tevas manufacturing facility in Buffalo NY which pr...
Merck and Samsung BioLogics Expand Strategic Alliance
Thursday, November 02, 2017Merck a leading science and technology company today announced the signing of a Memorandum of Understanding MoU with Samsung BioLogics for a strategic alliance to manufacture biopharmaceutical products and the development of biological processes...
Arcturus Therapeutics and Synthetic Genomics Announce Strategic Alliance to Develop Next-Generation Vaccines and Therapeutics
Wednesday, November 01, 2017Arcturus Therapeutics Inc a leading RNA medicines company and Synthetic Genomics Inc announced today that they have entered into a research collaboration and worldwide license agreement to develop selfamplifying RNAbased vaccines and therapeutics in...
Impel NeuroPharma Announces First Patient Dosed in Phase 1 Clinical Trial of INP104 for Treatment of Acute Migraine Headache
Wednesday, November 01, 2017Impel NeuroPharma a Seattlebased privatelyheld biotechnology company focused on therapies for the treatment of central nervous system CNS disorders today announced that the first patient was dosed in the recentlyinitiated Phase clinical trial of INP...
Lannett And Celgene Enter Into Settlement And License Agreement Related To Thalomid®
Tuesday, October 31, 2017Lannett Company Inc announced that it has entered into a settlement and license agreement with Celgene Corporation that resolves patent infringement litigation in the US related to Celgenes Thalomid The license agreement permits Lannett to manufactur...
Xynomic Pharma Acquires Global Rights of Boehringer Ingelheim's BI 882370
Tuesday, October 31, 2017Xynomic Pharma a clinical stage US oncology drug development company today announced that it has acquired exclusive global rights to develop manufacture and commercialize BI a ndgeneration RAF inhibitor from Boehringer Ingelheim a top global pharmac...
Zydus receives final approval from the USFDA for Tamoxifen Citrate Tablets USP
Monday, October 30, 2017Zydus Cadila has received the final approval from the USFDA to market Tamoxifen Citrate Tablets USP in the strengths of mg base and mg base The drug is indicated to treat breast cancer in women and men and to reduce the incidence of breast cancer i...
